Found 2 clinical trials
Featured trial
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study) (PADSTONE)
It does not require large volumes of plasma and nor does it bear the risk of plasma-associated allergic reaction or disease transmissions. PMAS can attenuate the jaundice in a short term and decrease the bilirubin concentration, which then reduces the toxicities of bile acid and high levels of bilirubin on …
- 0 views
- 23 Nov, 2021
- 1 location
Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
At least 13 hospitals in China will participate in the study, which aims to clarify the natural history of jaundice in Chinese healthy newbornsand decrease the incidence of severe hyperbilirubinemia and acute bilirubin encephalopathy and even kernicterus.
hyperbilirubinemia
jaundice
kernicterus
- 0 views
- 16 Feb, 2024
- 1 location